| Serial Number | 79377485 |
| Word Mark | LENTICLAIR |
| Filing Date | Thursday, July 13, 2023 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Friday, March 29, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Medical and scientific research in the fields of respiratory diseases and inflammatory diseases; medical and scientific research in the field of cell and gene therapies; providing medical and scientific research information in the field of respiratory diseases and inflammatory diseases; providing medical and scientific research information in the field of cell and gene therapies |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 1, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Thursday, January 1, 1970 |
| First Use In Commerce Date | Thursday, January 1, 1970 |
| Party Name | Boehringer Ingelheim International GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | DE |
| Event Date | Event Description |
| Thursday, August 31, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, March 8, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, March 12, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, March 29, 2024 | REFUSAL PROCESSED BY MPU |
| Friday, March 29, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, September 1, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 5, 2023 | APPLICATION FILING RECEIPT MAILED |
| Monday, March 11, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, April 24, 2024 | REFUSAL PROCESSED BY IB |